When scientists present, they usually start with methods, then move to findings, conclusions and perhaps recommendations. There are good reasons for this, and it can provide some drama. Yet any communication we are willing to pay for is built in… Read More »When Scientists Present
Like that moment in bowling, when your ball leaves two pins standing far apart, there are times when your audience is divided into two camps. One half is knowledgeable about your area of expertise, while the other half is green. … Read More »Public Speaking: Split Shot Audience
Despite the extraordinary contributions the pharmaceutical industry has made to the quality and longevity of human life, it stands charged in the court of public opinion on a multiple-count indictment. Below, I have listed what I believe are the sentiments,… Read More »Pharmaceutical Presentations: Pharma on Trial
A few years ago, I had a procedure done in a doctor’s office in which a small camera at the end of a tube was inserted into my body for the purpose of observing the inside of my bladder (you… Read More »Business Communication: How Pharma Can Build Trust
Charlie Green and I have been talking about how the good that pharma does gets undermined by certain of its marketing practices. Here’s a blog posting from Charlie’s website, www.trustedadvisor.com that should help us with our navel gazing. —– Pharma… Read More »Pharmaceutical Presentations: What Pharma Must Do to Regain Trust
With the average sales call in the pharmaceutical industry now shrunk to less than 30 seconds, medical liaisons have an important opportunity to engage the interest of key physicians at advisory board meetings. However, there are several common problems. First,… Read More »Facilitation skills for medical liaisons at ad boards